FDA Investigating Reports of COVID Relapses Following Use of Pfizer’s Pill

A Pfizer technician handles the company's COVID-19 pill, known as Paxlovid, in a file photograph. Pfizer via AP

The U.S. Food and Drug Administration (FDA) is investigating reports of relapses among people who took Pfizer’s COVID-19 pill.

The FDA “is evaluating the reports of viral load rebound after completing paxlovid treatment and will share recommendations if appropriate,” an agency spokesperson told The Epoch Times in an email.